大剂量人血丙种球蛋白在特发性血小板减少性紫癜治疗中的临床分析  

Clinical Analysis of High Dose Intravenous Injection Gamma Globulin in the Treatment of Idiopathic Thrombocytopenic Purpura

作　　者：陆时运[1] 赵晓红[1] 王智[1] 

机构地区：[1]无锡市第二人民医院血液科,江苏无锡214001

出　　处：《中国血液流变学杂志》2008年第1期80-81,共2页Chinese Journal of Hemorheology

摘　　要：目的分析大剂量静脉用人血丙种球蛋白(简称HDIVIG)治疗特发性血小板减少性紫癜(简称ITP)的疗效。方法在ITP患者的治疗中加用静注丙球400mg/kg/d,连用5d。结果HDIVIG治疗组48例,显效40例(83%),良效8例(17%);常规治疗组52例,显效28例(53%),良效14例(27%),进步5例(10%),无效5例(10%)。结论大剂量静脉用人血丙种球蛋白的使用,对于严重的特发性血小板减少性紫癜是一种安全、有效的治疗方法。Objective To investigate curative effect of high dose intravenous injection gamma globulin(HDIVIG) therapy on idiopathic thrombocytopenic purpura(ITP).Methods Dosage of IVIG was 0.4g/kg/d,d1-5.Result HDIVIG therapy group,among 48 patients,40 patients(83%)with ITP achieved remarkably excellent effects,8 patients (17%) acquired good effects;Convetional therapy group,among 52 patients,28 patients(53%) achieved remarkably excellent effects,14 patients (27%) acquired good effects,5 patients (10%) improved and 5 ...

关 键 词：丙种球蛋白 特发性血小板减少性紫癜 

分 类 号：R554.6[医药卫生—血液循环系统疾病]